Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model

Zeinab Ghazvinian ¹ , Shahrokh Abdolahi ¹, Mohammad Ahmadvand ², Amir Hossein Emami ³, Samad Muhammadnejad ⁴, Hamid Asadzadeh Aghdaei ⁵, Jafar Ai ⁶, Mohammad Reza Zali ⁷, Iman Seyhoun ¹, Javad Verdi ¹ * , Kaveh Baghaei ^5,7 *

Cited by CrossRef: 2

1- Wang Y, Wang T, Zhang Y. A Case Report of Pathologically Complete Response of a Huge Lymph Node Metastasis of Colorectal Cancer After Treatment with Intratumoral Oncolytic Virus H101 and Capecitabine. ITT. 2024;Volume 13:343 [Crossref]

2- Kang M, Kim D. Anti-Cancer Effects of the Pandanus tectorius Parkinson Extract: Reduction of YAP and TAZ Levels via Inhibition of the Hippo and Notch Signaling Pathways. Biomed Sci Letters. 2024;30(3):113 [Crossref]

3- Ghazvinian Z, Abdolahi S, Tokhanbigli S, Tarzemani S, Piccin A, Reza Zali M, Verdi J, Baghaei K. Contribution of natural killer cells in innate immunity against colorectal cancer. Front Oncol. 2023;12 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons